{"DataElement":{"publicId":"5040139","version":"2","preferredName":"Acute Graft Versus Host Disease Overall Grade","preferredDefinition":"Information related to the overall grade of acute graft versus host disease.","longName":"5040137v1.0:2680968v2.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"5040137","version":"1","preferredName":"Acute Graft Versus Host Disease Overall Grade","preferredDefinition":"A syndrome of immologically mediated tissue damage occurring following allogeneic transplant usually affecting the skin, liver, and gi tract.  Onset is usually within one hundred days of transplantation or immunologic manipulation._Including everything._A position on a scale of intensity or amount or quality.","longName":"2512823v1.0:5040135v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2512823","version":"1","preferredName":"Acute Graft Versus Host Disease","preferredDefinition":"A graft versus host disease with symptoms appearing within the first 100 days post-transplant, but with short duration.","longName":"C4980","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acute Graft Versus Host Disease","conceptCode":"C4980","definition":"A syndrome of immunologically mediated tissue damage that may occur following an allogeneic transplant, usually affecting the skin, liver, and GI tract. The onset is usually within one hundred days of transplantation or immunologic manipulation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B898438-B0B8-35BB-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-08-21","endDate":null,"createdBy":"UMLLOADER_AGNIS","dateCreated":"2006-08-21","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"5040135","version":"1","preferredName":"Overall Grade","preferredDefinition":"Including everything.:A position on a scale of intensity or amount or quality.","longName":"C25605:C48309","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Overall","conceptCode":"C25605","definition":"Including everything.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Grade","conceptCode":"C48309","definition":"A position on a scale of intensity or amount or quality.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2340DD99-4AA4-5DFA-E050-BB89AD431154","latestVersionIndicator":"Yes","beginDate":"2015-10-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-10-29","modifiedBy":"ONEDATA","dateModified":"2015-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2340DD99-4AB5-5DFA-E050-BB89AD431154","latestVersionIndicator":"Yes","beginDate":"2015-10-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-10-29","modifiedBy":"NYCHM","dateModified":"2017-01-31","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2680968","version":"2","preferredName":"Acute Graft Versus Host Disease Overall Grade","preferredDefinition":"A syndrome of immologically mediated tissue damage occurring following allogeneic transplant usually affecting the skin, liver, and gi tract.  Onset is usually within one hundred days of transplantation or immunologic manipulation._Including everything._A position on a scale of intensity or amount or quality.","longName":"2680968v2.0","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"60","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Not applicable","valueDescription":"Not Applicable","ValueMeaning":{"publicId":"5035616","version":"1","preferredName":"Not Applicable","longName":"5035616","preferredDefinition":"Determination of a value is not relevant in the current context.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Applicable","conceptCode":"C48660","definition":"Determination of a value is not relevant in the current context.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"223B305D-E0E3-6C83-E050-BB89AD433DFD","latestVersionIndicator":"Yes","beginDate":"2015-10-16","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-10-16","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2C86262B-2FCC-2E71-E050-BB89AD434A15","beginDate":"2015-10-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-24","modifiedBy":"ONEDATA","dateModified":"2016-02-24","deletedIndicator":"No"},{"value":"IV","valueDescription":"AGVHD Grade IV","ValueMeaning":{"publicId":"5131132","version":"1","preferredName":"AGVHD Grade IV","longName":"5131132","preferredDefinition":"Generalized erythroderma with bullous formation, or bilirubin >15 mg/dL","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2C868267-40AE-475A-E050-BB89AD4350B6","latestVersionIndicator":"Yes","beginDate":"2016-02-24","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2C868267-40C6-475A-E050-BB89AD4350B6","beginDate":"2016-02-24","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-24","modifiedBy":"ONEDATA","dateModified":"2016-02-24","deletedIndicator":"No"},{"value":"III","valueDescription":"AGVHD Grade III","ValueMeaning":{"publicId":"5131133","version":"1","preferredName":"AGVHD Grade III","longName":"5131133","preferredDefinition":"Bilirubin 3-15 mg/dL, or gut stage 2-4 diarrhea > 1000 mL/day or severe abdominal pain with or without ileus","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2C868267-40D0-475A-E050-BB89AD4350B6","latestVersionIndicator":"Yes","beginDate":"2016-02-24","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2C868267-40E8-475A-E050-BB89AD4350B6","beginDate":"2016-02-24","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-24","modifiedBy":"ONEDATA","dateModified":"2016-02-24","deletedIndicator":"No"},{"value":"II","valueDescription":"AGVHD Grade II","ValueMeaning":{"publicId":"5131134","version":"1","preferredName":"AGVHD Grade II","longName":"5131134","preferredDefinition":"Rash on > 50% of skin, bilirubin 2-3 mg/dL, or diarrhea 500 - 1000 mL/day or persistent nausea or vomiting","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2C868267-40F2-475A-E050-BB89AD4350B6","latestVersionIndicator":"Yes","beginDate":"2016-02-24","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-24","modifiedBy":"COOPERM","dateModified":"2019-04-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2C868267-410A-475A-E050-BB89AD4350B6","beginDate":"2016-02-24","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-24","modifiedBy":"ONEDATA","dateModified":"2016-02-24","deletedIndicator":"No"},{"value":"I","valueDescription":"AGVHD Grade I","ValueMeaning":{"publicId":"5131135","version":"1","preferredName":"AGVHD Grade I","longName":"5131135","preferredDefinition":"Rash on <= 50% of skin, no liver or gut involvement","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2C868267-4114-475A-E050-BB89AD4350B6","latestVersionIndicator":"Yes","beginDate":"2016-02-24","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2C868267-412C-475A-E050-BB89AD4350B6","beginDate":"2016-02-24","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-24","modifiedBy":"ONEDATA","dateModified":"2016-02-24","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2785783","version":"1","preferredName":"Acute Graft Versus Host Disease Overall Grade","preferredDefinition":"A syndrome of immologically mediated tissue damage occurring following allogeneic transplant usually affecting the skin, liver, and gi tract.  Onset is usually within one hundred days of transplantation or immunologic manipulation.:Including everything.:A position on a scale of intensity or amount or quality.","longName":"C4980:C25605:C48309","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acute Graft Versus Host Disease","conceptCode":"C4980","definition":"A syndrome of immunologically mediated tissue damage that may occur following an allogeneic transplant, usually affecting the skin, liver, and GI tract. The onset is usually within one hundred days of transplantation or immunologic manipulation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Overall","conceptCode":"C25605","definition":"Including everything.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Grade","conceptCode":"C48309","definition":"A position on a scale of intensity or amount or quality.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5719E926-F26B-27FA-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-09-17","endDate":null,"createdBy":"CZECHS","dateCreated":"2008-09-17","modifiedBy":"ONEDATA","dateModified":"2008-09-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2C86262B-2F6F-2E71-E050-BB89AD434A15","latestVersionIndicator":"Yes","beginDate":"2016-02-24","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-24","modifiedBy":"COOPERM","dateModified":"2019-04-25","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"TPST_GVHD_agvhd_overall_gr","type":"NMDP_FN","context":"NHLBI"},{"name":"CPST_GVHD_agvhd_overall_gr","type":"NMDP_FN","context":"NHLBI"},{"name":"HPST_AGHD_agvhd_overall_gr","type":"NMDP_FN","context":"NHLBI"}],"ReferenceDocuments":[{"name":"What was the overall grade of","type":"Preferred Question Text","description":"What was the overall grade of acute graft versus host disease?","url":null,"context":"NHLBI"},{"name":"Overall grade of acute GVHD at diagnosis","type":"Application Standard Question Text","description":"Overall grade of acute GVHD at diagnosis","url":null,"context":"NHLBI"},{"name":"Overall grade of acute GVHD","type":"Alternate Question Text","description":"Overall grade of acute GVHD","url":null,"context":"NHLBI"},{"name":"Overall grade of acute GVHD at diagnosis","type":"Alternate Question Text","description":"Overall grade of acute GVHD at diagnosis","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4E32323-16A2-13CA-E053-4EBD850A484C","latestVersionIndicator":"Yes","beginDate":"2020-11-24","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-11-24","modifiedBy":"KUMMEROA","dateModified":"2021-08-20","changeDescription":"Released. 12/03/2020 KMM; .Previous version retired due to using newer version VD for PV def updates. 11/24/2020 KMM","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}